RELYVRIO (sodium phenylbutyrate and taurursodiol), for oral suspension
RELYVRIO is a prescription medicine used for the treatment of amyotrophic lateral sclerosis (ALS) in adults. Brand Name: RELYVRIO (sodium phenylbutyrate and taurursodiol), for oral suspension Initial U.S. Approval: 2022
Home | Rsodium phenylbutyrate and taurursodiol
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
RELYVRIO (sodium phenylbutyrate and taurursodiol)
Sodium phenylbutyrate/ursodoxicoltaurine is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
RELYVRIO is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults. The recommended initial dosage of RELYVRIO for oral suspension is 1 packet (3 g sodium phenylbutyrate and 1 g taurursodiol) daily for the first 3 weeks.
Sodium phenylbutyrate/ursodoxicoltaurine, also known as sodium phenylbutyrate/taurursodiol and sold under the brand name Albrioza among others, is a fixed-dose combination medication used for the treatment of amyotrophic lateral sclerosis (ALS). It contains sodium phenylbutyrate and ursodoxicoltaurine (taurursodiol). The combination was approved for medical use in Canada as Albrioza, in June 2022, and in the United States, as Relyvrio, in September 2022.
Drug (Brand / Generic): RELYVRIO / sodium phenylbutyrate and taurursodiol
Current Indications: amyotrophic lateral sclerosis (ALS)
Marketed by:: Amylyx Pharmaceuticals, Inc.
Approval Date: 2022
Dosage forms and strengths of RELYVRIO (sodium phenylbutyrate and taurursodiol)
For oral suspension: 3 g sodium phenylbutyrate and 1 g taurursodiol in singledose packets
Find Reference Updates
Alleviare Life Sciences
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ RELYVRIO (sodium phenylbutyrate and taurursodiol), for Injection ”. Confirmation of the order for RELYVRIO (sodium phenylbutyrate and taurursodiol), for Injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Get Access to Treatment – RELYVRIO
We have delivered medicines to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha